{"version":"1.0","provider_name":"CUTIS LAXA INTERNATIONALE","provider_url":"https:\/\/www.cutislaxa.org\/fr\/","title":"Nouvelles mutations  (ATP6V1E1, ATP6V1A) - CUTIS LAXA INTERNATIONALE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"aSdl9NhsrU\"><a href=\"https:\/\/www.cutislaxa.org\/fr\/new-mutations-atp6v1e1-atp6v1a\/\">Nouvelles mutations   <u>(ATP6V1E1, ATP6V1A)<\/u><\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.cutislaxa.org\/fr\/new-mutations-atp6v1e1-atp6v1a\/embed\/#?secret=aSdl9NhsrU\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Nouvelles mutations   &lt;u&gt;(ATP6V1E1, ATP6V1A)&lt;\/u&gt;\u00a0\u00bb &#8212; CUTIS LAXA INTERNATIONALE\" data-secret=\"aSdl9NhsrU\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.cutislaxa.org\/wp-content\/uploads\/2017\/07\/gene-small.jpg","thumbnail_width":300,"thumbnail_height":169,"description":"ATP6V1E1 ou ATP6V1A, sont les nouvelles mutations publi\u00e9es par une \u00e9quipe de chercheurs incluant, entre autres, Mmes Gardeitchik, Mohammed, De Paepe, Malfait et Morava ainsi que Mrs Kornak, Wevers et Callewaert, chercheurs avec qui nous sommes en lien. Ces mutations peuvent \u00eatre incluses dans la Cutis Laxa Autosomale R\u00e9cessive type 2 (ARCL2). Elles entrainent des [&hellip;]"}